Platelet Deposition Induced by Severely Damaged Vessel Wall Is Inhibited by a Boroarginine Synthetic Peptide with Antithrombin Activity

Summary

Thrombin plays a key role in platelet activation and thrombosis. Specific inhibition of thrombin appears to be one of the best approaches to prevent thrombus formation. We have studied the effects of a synthetic a-aminoboronic acid derivative - [Ac, (D) Phe-Pro-Boro-Arg-Hydrocloric acid] - on platelet deposition on severely damaged arterial wall. Platelet deposition was evaluated under well characterized rheological conditions in an original perfusion chamber and detected by autologous ^mIn-labeled platelets. The study was performed “in vivo” in a porcine model of arterial thrombosis triggered by severely damaged vessel wall at blood flow conditions mimicking mild stenosis (1690 s⁻¹) and patent (212 s⁻¹) vessels. In addition, ex-vivo platelet aggregation activity was evaluated by whole blood impedance aggregometry using collagen, ADP and thrombin as agonists. The synthetic a-aminoboronic peptide was intravenously administered as a bolus followed by continuous infusion. Ex vivo thrombin-induced whole blood platelet aggregation was totally abolished, while ADP- and Collagen-induced whole blood platelet aggregation was not modified. The effects of the synthetic antithrombin on platelet deposition were evaluated in native blood (non-anticoagulated) conditions and in combination with heparin. Under both experimental conditions, the synthetic peptide significantly inhibited platelet deposition at local flow conditions of both high (1690 s⁻¹) and low (212s⁻¹) shear rates. Our results suggest that specific inhibition of locally generated thrombin might be a good strategy to prevent platelet dependent arterial thrombus formation independently of the local flow shear rate of the area at risk.

• References

• 1 Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: Effects of hirudins heparin and calcium chelation. Blood 1991; 78: 423-434
• 2 Badimon L, Merino A, Badimon JJ, Fuster V. Hirudin and other thrombin inhibitors: experimental results and potential clinical applications. Trends in Cardiovascular Medicine 1991; 1: 261-267
• 3 Chesebro JH, Zoldhelyi P, Badimon L, Fuster V. Role of thrombin in arterial thrombosis: implications for therapy. Thromb Haemostas 1991; 66: 1-5
• 4 Knabb RM, Kettner CA, Timmerman PB, Reilly TM. In vivo characterization of a new synthetic thrombin inhibitor. Thromb Haemostas 1992; 67: 56-59
• 5 Chiu AT, Mousa SA, Pease LJ, Roscoe WA, Bozarth JM, Reilly TM, Smith RD, Timmermans PB. Inhibition of the Thrombin-Platelet Reactions by DuP 714. Biochem Biophys Res Comm 1991; 179: 1500-1508
• 6 Knabb RM, Kettner CA, Reilly TM. Thrombin Inhibition with DuP 714. Accelerates Reperfusion and Delays Reocclusion in Dogs Circulation 1993; 91: A 1860
• 7 Kettner C, Mersinger L, Knabb R. The selective inhibition of thrombin by peptides of Boroarginine. J Biol Chem 1990; 265: 18289-18297
• 8 Knabb RM, Shaw JH, Luettgen JM, Kettner CA, Timmermans PB, Reilly TM. Prevention of coronary thrombosis after oral administration of DuP 714, a Synthetic Thrombin Inhibitor. Circulation 1993; 91: A 2304
• 9 Badimon L, Fuster V, Chesebro JH, Dewanjee MK. New ex vivo radioisotopic method of quantitation of platelet deposition: studies in four animals species. Thromb Haemostas 1983; 50: 639-644
• 10 Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition: ex vivo study in a swine model. Arteriosclerosis 1986; 6: 312-320
• 11 Badimon L, Badimon JJ, Vallabhajosula S, Fuster V. Platelet thrombus formation on Collagen Type I. A model of Deep Vessel Injury Influence of Blood Rheology von Willebrand Factor and Blood Coagulation. Circulation 1988; 78: 1431-1442
• 12 Badimon L, Turitto VT, Rosemark JA, Badimon JJ, Fuster V. Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium Ill-labeled platelets on Collagen, subendothelium, and expanded polytetrafluoroethylene. J Lab Clin Med 1987; 110: 706-718
• 13 Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Thrombin Regulation of Platelet Interaction with Damaged Vessel Wall and Isolated Collagen Type I at Arterial Flow Conditions in a Porcine Model: Effects of Hirudins, Heparin, and Calcium Chelation. Blood 1991; 78: 423-434
• 14 Turitto VT, Baumgartner HR. Platelet-surface interactions. In: Hemostasis and Thrombosis: Basic principles and clinical practice Colman RH, Hirsh J, Marder UJ, Saltmann EW. (eds) Philadelphia: Lippincott Company; 1982: 364-379
• 15 Merrill EW. Rheology of blood. Physiological Review 1969; 49: 863-888
• 16 Copley AL. On biorheology (Joint plenary lecture). Biorheology 1973; 10: 87-105
• 17 Galvez A, Badimon L, Badimon JJ, Fuster V. Electrical Aggregometry in Whole Blood from Human, pig and rabbit. Thromb Haemostas 1986; 56: 128-132
• 18 Heras M, Chesebro JH, Webster MWI, Mruk JS, Grill D, Penny W, Bowie W, Badimon L, Fuster V. Hirudin, Heparin and Placebo During Deep Arterial Injury in the Pig The in vivo Role of Thrombin in Platelet-Mediated Thrombosis. Circulation 1990; 82: 1476-1484
• 19 Lam JYT, Chesebro JH, Steel P, Heras M, Webster M, Badimon L, Fuster V. Antithrombotic Therapy for Deep Arterial Injury by Angioplasty Efficacy of Common Platelet Inhibition Compared with Thrombin Inhibition in Pigs. Circulation 1991; 84: 814-820
• 20 Badimon L, Chesebro JH, Badimon JJ. Thrombus Formation on Ruptured Atherosclerotic Plaques and Rethrombosis on Evolving Thrombi. Circulation 1992; 86 [Suppl III]: III-74-III-85